Hormonal

Endocrine therapy, also known as hormone therapy, is a specialized treatment used primarily for cancers that are "hormone-sensitive." Certain types of cancer cells, particularly in the breast, prostate, and uterus, rely on natural hormones like estrogen or testosterone to grow and multiply. Endocrine therapy works by either lowering the levels of these hormones in the body or by blocking the cancer cells' ability to use them, effectively "starving" the tumor of its primary fuel source.

What is Endocrine therapy and How Does it Work?

Endocrine therapy functions as the body’s "Fuel Cut-off Valve." In hormone-sensitive cancers, hormones act like high-octane gasoline for an engine (the tumor). This therapy works by either "shutting off the gas pump" (preventing the body from producing the hormone) or by "clogging the fuel line" (blocking the receptors on the cancer cell so the hormone can't get in). Without this "fuel," the cancer cells lose their signal to grow and eventually stop dividing or die off.

Clinical Indications and Conditions Managed

This therapy is a cornerstone for long-term management and prevention of recurrence in specific oncology cases:

  • Hormone Receptor-Positive Breast Cancer: Blocking estrogen to prevent tumor growth.

  • Prostate Cancer: Reducing androgen (testosterone) levels to slow the progression of the disease.

  • Endometrial Cancer: Managing hormone levels to control uterine lining malignancies.

  • Ovarian Cancer: In specific cases where tumors are sensitive to hormonal fluctuations.

Mechanism of Action

Imagine a cancer cell as a "Locked Room" that needs a specific "Hormone Key" to open the door to growth. Endocrine therapy works in two main ways. Some drugs act like "Lock-Blockers" (Antagonists)—they shove a "broken key" into the lock so the real hormone key can't fit. Other drugs act like "Key-Snatchers" (Aromatase inhibitors or LHRH agonists)—they stop the body’s "factory" from making the keys in the first place. With the "growth door" locked shut, the cancer cell remains dormant or dies.

Expert Pharmacist Insight

Endocrine therapy is often a long-term commitment, sometimes lasting 5 to 10 years after initial cancer treatment. Because it changes the body's hormonal balance, patients may experience symptoms similar to menopause or andropause, such as hot flashes or changes in bone density. It is essential to monitor bone health with DEXA scans and ensure adequate calcium and Vitamin D intake. Adherence is key; even though these are often "just a daily pill," they are powerful tools in preventing the cancer from ever returning.

Frequently Asked Questions (Q&A)

Is endocrine therapy the same as "Hormone Replacement Therapy" (HRT)?
No, they are opposites. HRT adds hormones to the body to relieve symptoms, while endocrine therapy removes or blocks hormones to stop cancer from growing.

Will I lose my hair with hormone therapy?
Generally, no. Unlike traditional chemotherapy, endocrine therapy does not usually cause significant hair loss, though some patients may notice slight thinning over time.

How long do I need to take this medication?
In many cases of breast cancer, endocrine therapy is prescribed for 5 to 10 years to ensure the lowest possible risk of the cancer coming back.

Can men receive endocrine therapy?
Yes, it is the primary systemic treatment for prostate cancer, focusing on reducing testosterone levels to control tumor growth.

What are the most common side effects?
Since the body is adjusting to lower hormone levels, common effects include hot flashes, night sweats, joint pain, and changes in mood or libido.

Does endocrine therapy affect bone strength?
Yes, lowering estrogen or testosterone can lead to bone thinning (osteoporosis). Doctors often monitor bone density and may prescribe bone-strengthening medications alongside the therapy.

Can I get pregnant while on endocrine therapy?
Most endocrine therapies are not safe during pregnancy and can affect fertility. It is vital to discuss family planning and contraception with your oncologist before starting.

What happens if I stop taking the pills early?
Stopping early significantly increases the risk of the cancer returning. If side effects are difficult, talk to your doctor about switching to a different type of hormone blocker rather than stopping entirely.

Letromara 2.5 mg 30 tablets — Made in Ukraine — Free Delivery
In Stock
Pharmacological propertiesPharmacodynamics. Letrozole - a non-steroidal aromatase inhibitor (inhibitor of estrogen biosynthesis); anticancer preparation.Letrozole inhibits aromatase by competitive binding with the subunit of this enzyme - cytochrome P450 heme, which leads to a decrease in estrogen b..
Femara 2.5mg 30 tablets — Made in Switzerland — Free Delivery
In Stock
Product descriptionFemara® tablets are used for the following indications:adjuvant therapy of hormone-positive invasive breast cancer in the early stages in postmenopausal women;extended adjuvant therapy for early invasive breast cancer in postmenopausal women who have received standard adjuvant tam..
Etruzil 2.5mg 30 tablets — Made in Hungary — Free Delivery
In Stock
Product descriptionEtruzil tablets are used for the following indications:adjuvant therapy of hormone-positive invasive breast cancer in the early stages in postmenopausal women;extended adjuvant therapy for early invasive breast cancer in postmenopausal women who have received standard adjuvant tam..
LetroVista 2.5 mg 30 tablets — Made in Spain — Free Delivery
In Stock
Product descriptionLetroVista film-coated tablets are indicated for:Adjuvant therapy for hormone-positive invasive breast cancer in early stages in postmenopausal women.Advanced adjuvant therapy for early invasive breast cancer in postmenopausal women who have received standard adjuvant tamoxif..
Flutamide 250 mg 84 tablets — Made in Finland — Free Delivery
5-10 Days
Product descriptionFlutamide tablets are used for the following indications:treatment of locally advanced or metastatic prostate cancer, either as monotherapy (with or without orchidectomy) or in combination with luteinizing hormone releasing hormone (LHRH) agonists, in patients who have not previou..
Aralet 2.5mg 30 tablets — Made in Greece — Free Delivery
In Stock
Product descriptionAralet film-coated tablets are indicated for:Adjuvant therapy for hormone-positive invasive breast cancer in early stages in postmenopausal women.Advanced adjuvant therapy for early invasive breast cancer in postmenopausal women who have received standard adjuvant tamoxifen therap..
Letrozole-Teva 2.5 mg 30 capsules — Made in Hungary — Free Delivery
In Stock
Product descriptionLetrozole-Vista film-coated tablets are indicated for:Adjuvant therapy for hormone-positive invasive breast cancer in early stages in postmenopausal women.Advanced adjuvant therapy for early invasive breast cancer in postmenopausal women who have received standard adjuvant tamoxif..
Letrozole-Vista 2.5 mg 100 tablets — Made in Romania — Free Delivery
In Stock
Product descriptionLetrozole-Vista film-coated tablets are indicated for:Adjuvant therapy for hormone-positive invasive breast cancer in early stages in postmenopausal women.Advanced adjuvant therapy for early invasive breast cancer in postmenopausal women who have received standard adjuvant tamoxif..
Letrozole KRKA 2.5mg 90 tablets — Made in Slovenia — Free Delivery
In Stock
Product descriptionLetrozole KRKA film-coated tablets are indicated for:Adjuvant therapy for hormone-positive invasive breast cancer in early stages in postmenopausal women.Advanced adjuvant therapy for early invasive breast cancer in postmenopausal women who have received standard adjuvant tamoxife..
Letrozole-Vista 2.5 mg 30 tablets — Made in Romania — Free Delivery
In Stock
Product descriptionLetrozole-Vista film-coated tablets are indicated for:Adjuvant therapy for hormone-positive invasive breast cancer in early stages in postmenopausal women.Advanced adjuvant therapy for early invasive breast cancer in postmenopausal women who have received standard adjuvant tamoxif..
Letrozole KRKA 2.5mg 30 tablets — Made in Slovenia — Free Delivery
In Stock
Product descriptionLetrozole KRKA film-coated tablets are indicated for:Adjuvant therapy for hormone-positive invasive breast cancer in early stages in postmenopausal women.Advanced adjuvant therapy for early invasive breast cancer in postmenopausal women who have received standard adjuvant tamoxife..
Letero 2.5mg 30 tablets — Made in India — Free Delivery
In Stock
Product descriptionFilm-coated tablets Letero are indicated for:Adjuvant therapy for hormone-positive invasive breast cancer in early stages in postmenopausal women.Advanced adjuvant therapy for early invasive breast cancer in postmenopausal women who have received standard adjuvant tamoxifen therap..
Showing 1 to 12 of 12 (1 Pages)

Buyers Online

AI Pharmacist • VEV.ICU

Online | Multilingual

v2.24
Hi! I am your AI assistant. Describe your problem, and I'll help you find the right medicine.
You can write to me in any language you prefer.
I don't answer technical questions (prices, delivery, payments).